Confirmation of-174G/C interleukin-6 gene promoter polymorphism as a genetic marker predicting antitumor necrosis factor treatment outcome

Author(s):
Davila-Fajardo, C.L.; Marquez, A.; Pascual-Salcedo, D.; Ramos, M.J.M.; Garcia-Portales, R.; Magro, C.; Alegre-Sancho, J.J.; Balsa, A.; Cabeza-Barrera, J.; Raya, E.; Martin, J.
Published
2014
Publication type
Article / Letter to editor
antitumor necrosis factorinterleukin-6pharmacogeneticsrheumatoid arthritissingle-nucleotide polymorphism
Date issued
2014-01-31
Language
English
Is part of
Pharmacogenetics and Genomics (2014), Vol. 24, no. 1, p. 1-5
hdl
1887/95398
doi
10.1097/FPC.0000000000000013